Validation pour Ingenuity289

vers la météo de la validation par utilisateur

Ingenuity289

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 72 - PMID ?

In preglomerular artery from SP kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of SP NODE protein that is decreased by NODE .

name="reponse" value="NA"> Non annotée
name="reponse" value="JSP"> Je ne sais pas
name="reponse" value="INS"> Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

<?php echo $Com ; ?>

name="reponse" value="A0">Analyse 0

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                                   
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A1">Analyse 1

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                                   
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A2">Analyse 2

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A3">Analyse 3

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A4">Analyse 4

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A5">Analyse 5

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A6">Analyse 6

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A7">Analyse 7

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A8">Analyse 8

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                                   
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A9">Analyse 9

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A10">Analyse 10

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A11">Analyse 11

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A12">Analyse 12

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A13">Analyse 13

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A14">Analyse 14

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A15">Analyse 15

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A16">Analyse 16

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A17">Analyse 17

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A18">Analyse 18

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A19">Analyse 19

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A20">Analyse 20

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A21">Analyse 21

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A22">Analyse 22

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A23">Analyse 23

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A24">Analyse 24

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A25">Analyse 25

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A26">Analyse 26

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A27">Analyse 27

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A28">Analyse 28

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A29">Analyse 29

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A30">Analyse 30

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A31">Analyse 31

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A32">Analyse 32

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A33">Analyse 33

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A34">Analyse 34

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A35">Analyse 35

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A36">Analyse 36

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A37">Analyse 37

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A38">Analyse 38

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A39">Analyse 39

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+                        |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A40">Analyse 40

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A41">Analyse 41

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A42">Analyse 42

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A43">Analyse 43

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A44">Analyse 44

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A45">Analyse 45

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+                        |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A46">Analyse 46

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A47">Analyse 47

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A48">Analyse 48

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A49">Analyse 49

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A50">Analyse 50

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A51">Analyse 51

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A52">Analyse 52

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A53">Analyse 53

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A54">Analyse 54

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A55">Analyse 55

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A56">Analyse 56

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A57">Analyse 57

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A58">Analyse 58

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A59">Analyse 59

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A60">Analyse 60

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A61">Analyse 61

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+                        |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A62">Analyse 62

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A63">Analyse 63

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A64">Analyse 64

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A65">Analyse 65

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+                        |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A66">Analyse 66

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A67">Analyse 67

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A68">Analyse 68

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A69">Analyse 69

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A70">Analyse 70

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                                                              
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A71">Analyse 71

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A72">Analyse 72

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+------------------OBJ:V-N------------------+                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     +COMP:V-N(by)+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,__NODE__)

name="reponse" value="A73">Analyse 73

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A74">Analyse 74

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A75">Analyse 75

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A76">Analyse 76

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A77">Analyse 77

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A78">Analyse 78

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A79">Analyse 79

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                                                        |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A80">Analyse 80

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                                   
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A81">Analyse 81

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A82">Analyse 82

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                                   
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A83">Analyse 83

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A84">Analyse 84

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A85">Analyse 85

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A86">Analyse 86

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A87">Analyse 87

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A88">Analyse 88

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A89">Analyse 89

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V-N--------------+     |                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A90">Analyse 90

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A91">Analyse 91

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A92">Analyse 92

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A93">Analyse 93

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A94">Analyse 94

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A95">Analyse 95

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A96">Analyse 96

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A97">Analyse 97

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V-N--------------+     |                  
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A98">Analyse 98

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A99">Analyse 99

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A100">Analyse 100

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A101">Analyse 101

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V-N--------------+     |            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A102">Analyse 102

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A103">Analyse 103

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V-N--------------+     |            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A104">Analyse 104

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A105">Analyse 105

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V-N--------------+     |                  
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |                  
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     +COMP:V_PASS-+     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A106">Analyse 106

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A107">Analyse 107

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A108">Analyse 108

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A109">Analyse 109

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +---------------SUBJ:V_PASS-N---------------+                  
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V-N--------------+     |                  
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |                  
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |                  
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     +COMP:V_PASS-+     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)
COMP:V_PASS-N(by) (decrease,__NODE__)

name="reponse" value="A110">Analyse 110

                                                                                                                                   +------------------------------------COMP:V-N(by)------------------------------------+     
                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V-N--------------+     |            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A111">Analyse 111

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+------------------------------------COMP:V-N(by)------------------------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
COMP:V-N(by) (increase,__NODE__)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A112">Analyse 112

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A113">Analyse 113

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+---------COMP:N-N(by)--------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A114">Analyse 114

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A115">Analyse 115

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A116">Analyse 116

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A117">Analyse 117

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+---------COMP:N-N(by)--------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A118">Analyse 118

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A119">Analyse 119

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A120">Analyse 120

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A121">Analyse 121

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V-N--------------+     |            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A122">Analyse 122

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A123">Analyse 123

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +---------------SUBJ:V-N--------------+     |            |     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+-------COMP:N-N(of)-------+          |     |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+          |     |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+          |     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,activity)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A124">Analyse 124

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A125">Analyse 125

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A126">Analyse 126

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                                   
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+---------COMP:N-N(by)--------+     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A127">Analyse 127

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+---------COMP:N-N(by)--------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A128">Analyse 128

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                             |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+--SUBJ:V_PASS-N-+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A129">Analyse 129

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                             |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

name="reponse" value="A130">Analyse 130

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A131">Analyse 131

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +---------------SUBJ:V_PASS-N---------------+            |     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+-------COMP:N-N(of)-------+                |            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-MOD_ATT:N-ADJ-+                |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          |       +MOD_ATT+                |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,protein)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,activity)

name="reponse" value="A132">Analyse 132

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +-------------COMP:N-N(by)------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A133">Analyse 133

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                              +-------------COMP:N-N(by)------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A134">Analyse 134

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-----------------COMP:N-N(by)----------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A135">Analyse 135

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                      +-----------------COMP:N-N(by)----------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A136">Analyse 136

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +-------------COMP:N-N(by)------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A137">Analyse 137

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                              +-------------COMP:N-N(by)------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A138">Analyse 138

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-----------------COMP:N-N(by)----------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A139">Analyse 139

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                      +-----------------COMP:N-N(by)----------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+          +-------------OBJ:V-N------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          |               +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A140">Analyse 140

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A141">Analyse 141

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A142">Analyse 142

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+                        |            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A143">Analyse 143

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A144">Analyse 144

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                                                                                          
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+----------------------COMP:N-N(by)----------------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +------------------OBJ:V-N------------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A145">Analyse 145

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A146">Analyse 146

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+                        |            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A147">Analyse 147

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    |                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          |                     +-------------COMP:N-N(of)------------+        +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
COMP:N-N(of) (nmol/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A148">Analyse 148

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +-------------COMP:N-N(by)------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A149">Analyse 149

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                              +-------------COMP:N-N(by)------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A150">Analyse 150

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +-------------COMP:N-N(by)------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+---------OBJ:V-N--------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A151">Analyse 151

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                              +-------------COMP:N-N(by)------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+                  +---------OBJ:V-N--------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A152">Analyse 152

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                                                                                          
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+          +-----------------COMP:N-N(by)----------------+     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |          +-------------OBJ:V-N------------+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+----SUBJ:V-N----+            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |                |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (__SP__,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

name="reponse" value="A153">Analyse 153

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+      +MOD_ATT:N-+          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |      |          |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
MOD_ATT:N-N (ciglitazone,kidney)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A154">Analyse 154

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          |                          +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          +COMP:N-N(o+       +MOD_ATT+-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__SP__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)

name="reponse" value="A155">Analyse 155

                                 +-------------------------------------------COMP:V-N(In)------------------------------------------+                                                                                          
                                 |                 +------------------------------------SUBJ:V-N-----------------------------------+                           +----------------------COMP:N-N(by)----------------------+     
                                 |                 |          +--------------------OBJ:V-N--------------------+                    +----------OBJ:V-N----------+------------------OBJ:V-N------------------+            |     
          +-----MOD_ATT:N-ADJ----+                 |          +-------OBJ:V-N-------+                         +COMP:N-N(of+        +--COMP:V-N(by)--+          +---COMP:N-N(of)---+       +----SUBJ:V-N----+            |     
          |          +MOD_ATT:N-N+                 |          |       +COMP:N+      |                +MOD_ATT:+       +MOD+        |           +MOD_+          |          +MOD_ATT+       +-SUBJ:V-N-+     |            |     
          |          |           |                 |          |       |      |      |                |        |       |   |        |           |    |          |          |       |       |          |     |            |     
 In preglomerular artery from __SP__ kidney , ciglitazone ( with a dosage of 9 nmol/kg/day and a treatment period of 21 days ) increases ( by 30 percent ) activity of __SP__ __NODE__ protein that is decreased by __NODE__ .
MOD_ATT:N-ADJ (__SP__,preglomerular)
MOD_ATT:N-N (__SP__,artery)
OBJ:V-N (with,nmol/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,9)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ciglitazone)
COMP:V-N(by) (increase,percent)
OBJ:V-N (increase,activity)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (activity,__NODE__)
COMP:N-N(by) (activity,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,activity)
SUBJ:V-N (decrease,protein)